Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone

David Rafei-Shamsabadi, Saskia Lehr, Dagmar von Bubnoff, Frank Meiss*

*Korrespondierende/r Autor/-in für diese Arbeit
10 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie